Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000892569-07-000055
Filing Date
2007-01-30
Accepted
2007-01-30 16:08:12
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q a26828ae10vqza.htm 10-Q/A 1370966
2 EXHIBIT 15.1 a26828aexv15w1.htm EX-15.1 4858
3 EXHIBIT 15.2 a26828aexv15w2.htm EX-15.2 2310
4 EXHIBIT 23 a26828aexv23.htm EX-23 1823
5 EXHIBIT 31.1 a26828aexv31w1.htm EX-31.1 9110
6 EXHIBIT 31.2 a26828aexv31w2.htm EX-31.2 9312
7 EXHIBIT 32.1 a26828aexv32w1.htm EX-32.1 6160
  Complete submission text file 0000892569-07-000055.txt   1406127
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-11397 | Film No.: 07564753
SIC: 2834 Pharmaceutical Preparations